Endodermasuccessfully acquired the final approval on permission to sell Endoskiin, aflagship cosmetic patch of dissolving CLHA microneedles  from China Foodand Drug Administration (CFDA) and became ready to enter into China.  

CFDAapproval, or China Food and Drug Administration approval, is a mandatoryprocedure for all cosmetic products to be commercialized in China.  Forthis approval, the products must be thoroughly analyzed and evaluated for thesafety matters such as skin irritation test, microbiological test and heavyl test through the official agency designated by CFDA. For theregistration, the submission of detailed report on the safety evaluation dataas well as product is required.  The CFDA approval can be obtained onlyafter CFDA’s stringent and rigorous screening and procedures.